Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-07

Clinical Trial Update: MuscleCare™ Pain Relief Therapy vs. Voltaren® in the Relief of Trapezius Trigger Point Musculoskeletal Pain. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing MuscleCare Pain Relief Therapy to Voltaren for trapezius trigger point musculoskeletal pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MuscleCare Pain Relief Therapy
  • Voltaren (Diclofenac)

Snippet

Sponsor: University of Toronto | Conditions: Pain | Phase 4 | Status: COMPLETED